부산대학교 도서관

Mogenet A; Greillier L; Tomasini P

Pharmacogenomics and Personalized Medicine, Vol 14, Pp 987-996 (2021)

Nikolaou V; 1st Department of Dermatology and Venereology, 'Andreas Sygros' Hospital for Skin Diseases, National & Kapodistrian University of Athens Medical School, Athens, Greece.; Mayor A; Servicio de Dermatología, Hospital Universitario La Paz, Madrid, Spain.; Sibaud V; Oncodermatology Department, Institut Claudius Regaud and Institut Universitaire du Cancer Toulouse Oncopole, Toulouse Cedex 9, France.; Giacchero D; Department of Medical Oncology, University Côte d'Azur, Centre Antoine Lacassagne, Nice, France.; Fattore D; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.; Apalla Z; 2nd Dermatology Department, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.; Sollena P; Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Starace M; Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Segura S; Dermatology Department, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Pompeu Fabra, Barcelona, Spain.; Nosrati A; Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel.; Torre AC; Dermatology Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.; Riganti J; Dermatology Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.; Grassi P; Dermatology and Skin Cancer Department, Aix Marseille University, Marseille Cedex 07, France.; Tomasini P; Dermatology and Skin Cancer Department, Aix Marseille University, Marseille Cedex 07, France.; Koumaki D; Department of Dermatology and Venereology, University Hospital of Heraklion, Crete, Greece.; Ducharme O; Department of Dermatology, CHU Bordeaux, Bordeaux, France.; Boujnah R; Department of Medical Oncology, University Côte d'Azur, Centre Antoine Lacassagne, Nice, France.; Koumprentziotis IA; 1st Department of Dermatology and Venereology, 'Andreas Sygros' Hospital for Skin Diseases, National & Kapodistrian University of Athens Medical School, Athens, Greece.; Rapparini L; Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Kraehenbuehl L; Department of Dermatology, Kantonsspital Aarau, Aarau, Switzerland.; Department of Dermatology, University Hospital of Zurich (USZ), University of Zurich (UZH), Zurich, Switzerland.; Swim across America and Ludwig Collaborative Laboratory, Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA.; Parker Institute for Cancer Immunotherapy and Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, New York, USA.; Freites-Martinez A; Department of Dermatology, Hospital Ruber de Juan Bravo, Universidad Europea, Madrid, Spain.; Gaudy-Marqueste C; Dermatology and Skin Cancer Department, Aix Marseille University, Marseille Cedex 07, France.; Oikonomou C; Department of Dermatology-Venereology, School of Medicine, University of Patras, Patras, Greece.; Grafanaki K; Department of Dermatology-Venereology, School of Medicine, University of Patras, Patras, Greece.; Agelaki S; Department of Dermatology and Venereology, University Hospital of Heraklion, Crete, Greece.; Radevic T; Department of Dermatology and Venereology, Medical Faculty of the Military Medical Academy, University of Defense, Belgrade, Serbia.; Charpidou A; Third Department of Internal Medicine, Sotiria Hospital, National, and Kapodistrian University of Athens, Athens, Greece.; Peris K; Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Lazaridou E; 2nd Dermatology Department, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.; Stratigos A; 1st Department of Dermatology and Venereology, 'Andreas Sygros' Hospital for Skin Diseases, National & Kapodistrian University of Athens Medical School, Athens, Greece.; Malissen N; Dermatology and Skin Cancer Department, Aix Marseille University, Marseille Cedex 07, France.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3083 (Electronic) Linking ISSN: 09269959 NLM ISO Abbreviation: J Eur Acad Dermatol Venereol Subsets: MEDLINE

Ranchon F; Hospices Civils de Lyon, Groupement Hospitalier Sud, Unité de Pharmacie Clinique Oncologique, Pierre-Bénite, France; Université Lyon 1, EA 3738, CICLY Centre pour l'Innovation en Cancérologie de LYon, 69921 Lyon, Oullins, France; Société Française de Pharmacie Oncologique (SFPO), Paris, France.; Slimano F; Société Française de Pharmacie Oncologique (SFPO), Paris, France; Université de Reims Champagne-Ardenne, BioSpeCT, CHU Reims, Pharmacie, 51100 Reims, France.; Ayyoub M; Université de Toulouse, Inserm, CNRS, Centre de recherches en cancérologie de Toulouse, UMR1037 - Oncopole Claudius Regaud, institut universitaire du cancer de Toulouse, Toulouse, France.; Bérard C; Service Pharmacie, Hôpital de la Timone, Assistance Publique des Hôpitaux de Marseille (AP-HM), Marseille, France.; Grand A; Unité essais cliniques et MTI, IUCT, Oncopôle, CHU, Toulouse, France.; Kroemer M; Unité de pharmacie clinique oncologique, CHU Besançon, UMR1098 RIGHT - EFS/BFC équipe TICI, Besançon, France.; Paoletti X; Direction de la Recherche Clinique Institut Curie, Université de Versailles St Quentin, INSERM U1331, équipe STAMPM, France.; Schwiertz V; Hospices Civils de Lyon, Groupement Hospitalier Sud, Unité de Pharmacie Clinique Oncologique, Pierre-Bénite, France.; Tomasini P; Aix-Marseille Univ, CRCM, INSERM, CNRS, APHM, Hopital la Timone, CEPCM, Marseille, France.; Bardin C; Société Française de Pharmacie Oncologique (SFPO), Paris, France; Parmacie clinique, CHU Cochin AP-HP. Centre-Université Paris Cité, Paris, France.; Raffoux E; Société Française de Pharmacie Oncologique (SFPO), Paris, France; Service d'hématologie, hôpital Saint-louis, AP-HP, France.; Rioufol C; Hospices Civils de Lyon, Groupement Hospitalier Sud, Unité de Pharmacie Clinique Oncologique, Pierre-Bénite, France; Université Lyon 1, EA 3738, CICLY Centre pour l'Innovation en Cancérologie de LYon, 69921 Lyon, Oullins, France; Société Française de Pharmacie Oncologique (SFPO), Paris, France.; Chevrier R; Société Française de Pharmacie Oncologique (SFPO), Paris, France; Jean Perrin Cancer Center, Pharmacie, Clermont-Ferrand, France.; Pourroy B; Société Française de Pharmacie Oncologique (SFPO), Paris, France; ONCOPHARM unit, La Timone University Teaching Hospital, AP-HM, Marseille, France.; Cazin JL; Société Française de Pharmacie Oncologique (SFPO), Paris, France; UFR 3S Pharmacie (Université de Lille), centre Oscar-Lambret, Lille, France. Electronic address: J-CAZIN@o-lambret.fr.

Publisher: Elsevier Masson Editeur Country of Publication: France NLM ID: 2985176R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2772-803X (Electronic) Linking ISSN: 00034509 NLM ISO Abbreviation: Ann Pharm Fr Subsets: MEDLINE

Tomasini P; Aix Marseille University - CNRS, INSERM, CRCM; CEPCM - AP-HM Hôpital de La Timone, Marseille, France.; Wang Y; Division of Thoracic Tumor Multimodality Treatment, Cancer Center and Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, China.; Li Y; Chongqing University Cancer Hospital, Chongqing, China.; Felip E; Medical Oncology Service, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.; Wu L; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.; Cui J; The First Hospital of Jilin University, Changchun, China.; Besse B; Paris-Saclay University, Institut Gustave Roussy, Villejuif, France.; Spira AI; Virginia Cancer Specialists, Fairfax, VA.; Neal JW; Stanford Cancer Institute, Stanford University, Stanford, CA.; Goto K; National Cancer Center Hospital East, Kashiwa, Japan.; Baik CS; University of Washington Fred Hutchinson Cancer Research Center, Seattle, WA.; Marmarelis ME; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Ichihara E; Center for Clinical Oncology, Okayama University Hospital, Okayama, Japan.; Zhang Y; Zhejiang Cancer Hospital, Hangzhou, China.; Lee JS; Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea.; Lee SH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Yang JC; National Taiwan University Cancer Center, Taipei, Taiwan.; Michels S; Department I for Internal Medicine, Faculty of Medicine and University Hospital Cologne, Lung Cancer Group Cologne, Center for Integrated Oncology Aachen Köln Bonn Düsseldorf, University of Cologne, Cologne, Germany.; Anastasiou Z; Johnson & Johnson, Athens, Greece.; Curtin JC; Johnson & Johnson, Spring House, PA.; Lyu X; Johnson & Johnson, Shanghai, China.; Mahoney J; Johnson & Johnson, Spring House, PA.; Demirdjian L; Johnson & Johnson, Brisbane, CA.; Meyer CS; Johnson & Johnson, Brisbane, CA.; Zhang Y; Johnson & Johnson, Raritan, NJ.; Leconte I; Johnson & Johnson, Allschwil, Switzerland.; Lorenzini P; Johnson & Johnson, Spring House, PA.; Knoblauch RE; Johnson & Johnson, Spring House, PA.; Trani L; Johnson & Johnson, Spring House, PA.; Baig M; Johnson & Johnson, Raritan, NJ.; Bauml JM; Johnson & Johnson, Spring House, PA.; Cho BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Tomasini P; Aix Marseille University Hospital Nord, Multidisciplinary Oncology and Therapeutic Innovations Department, Marseille, France. Electronic address: pascale.tomasini@ap-hm.fr.; Juan-Vidal O; Department of Medical Oncology, University Hospital La Fe, Valencia, Spain.; Califano R; The Christie NHS Foundation Trust and Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom.; Lin CC; National Cheng Kung University Hospital, Tainan, Taiwan.; Hulo P; Thoracic Oncology Unit, Nantes University Hospital, Nantes, France.; Dooms C; UZ Leuven, Leuven, Belgium.; Fang J; Beijing Cancer Hospital, Beijing, China.; Blasco A; Hospital General Universitario de Valencia, Valencia, Spain.; Kowalski D; Department of Lung Cancer and Chest Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Salinas J; CEMAIC Private Medical Center, Córdoba, Argentina.; Babu G; Health Care Global Enterprises pvt Ltd Bangalore, India.; Mun TL; Beacon Hospital Sdn. Bhd., Petaling Jaya, Malaysia.; Bearz A; Centro di Riferimento Oncologico di Aviano, Aviano, Italy.; Surmont V; UZ Gent, Gent, Belgium.; Baldotto C; Instituto D'Or de Pesquisa e Ensino (IDOR), Rio de Janeiro, Brazil.; Sharma R; Artemis Hospital, Gurugram Haryana, India.; Arrieta O; Medica Sur, Mexico City, Mexico.; Stencel K; Polish Mother's Memorial Hospital - Research Institute, Łódź, Poland; Wielkopolska Center of Pulmonology and Thoracic Surgery of Eugenia and Janusz Zeyland, Poznan, Poland.; Card C; Arnie Charbonneau Cancer Institute Calgary, Alberta, Canada.; Zer A; Rambam Health Care Corporation Campus, Tel-Aviv, Israel.; Massarelli E; City of Hope Comprehensive Cancer Center, Duarte, CA.; Fang B; Astera Cancer Care, East Brunswick, NJ.; Mashru S; Kaiser Permanente Northwest, Portland, OR.; Schuchard J; Johnson & Johnson, Horsham, PA.; Sermon J; Johnson & Johnson, Beerse, Belgium.; Diels J; Johnson & Johnson, Beerse, Belgium.; Chu PL; Johnson & Johnson, Raritan, NJ.; Withelder M; Johnson & Johnson, Malvern, PA.; Bauml JM; Johnson & Johnson, Spring House, PA.; Shah S; Johnson & Johnson, Raritan, NJ.; Baig M; Johnson & Johnson, Horsham, PA.; Felip E; Vall d'Hebron University Hospital Vall d'Hebron Institute of Oncology, Barcelona, Spain.

Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE

Vincent Y; Department of Thoracic and Vascular Surgery, Sainte Anne Military Teaching Hospital, Toulon, France; Department of Thoracic Surgery, Hôpital Nord, Assistance Publique-Hopitaux de Marseille, Aix-Marseille University, Marseille, France. Electronic address: Yohann-vincent2@hotmail.com.; Enoch F; Multidisciplinary Oncology and Therapeutic Innovations Department, Hôpital Nord, Assistance Publique-Hopitaux de Marseille, Aix-Marseille University, Marseille, France.; Pauly V; CEReSS-Health Service Research and Quality of Life Center, (EA, 3279) - Aix-Marseille University-Marseille, France.; Couderc AL; Aix-Marseille University, CNRS, EFS, ADES, Marseille, France; Internal Medicine, Geriatrics and Therapeutic Unit, APHM, France.; Tomasini P; Multidisciplinary Oncology and Therapeutic Innovations Department, Hôpital Nord, Assistance Publique-Hopitaux de Marseille, Aix-Marseille University, Marseille, France; Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France.; Greillier L; Multidisciplinary Oncology and Therapeutic Innovations Department, Hôpital Nord, Assistance Publique-Hopitaux de Marseille, Aix-Marseille University, Marseille, France; Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France.; Pluvy J; Multidisciplinary Oncology and Therapeutic Innovations Department, Hôpital Nord, Assistance Publique-Hopitaux de Marseille, Aix-Marseille University, Marseille, France.; D'Journo XB; Department of Thoracic Surgery, Hôpital Nord, Assistance Publique-Hopitaux de Marseille, Aix-Marseille University, Marseille, France.; Thomas PA; Department of Thoracic Surgery, Hôpital Nord, Assistance Publique-Hopitaux de Marseille, Aix-Marseille University, Marseille, France.; Fourdrain A; Department of Thoracic Surgery, Hôpital Nord, Assistance Publique-Hopitaux de Marseille, Aix-Marseille University, Marseille, France.; Mogenet A; Multidisciplinary Oncology and Therapeutic Innovations Department, Hôpital Nord, Assistance Publique-Hopitaux de Marseille, Aix-Marseille University, Marseille, France; Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France.

Publisher: Elsevier Country of Publication: England NLM ID: 8504356 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2157 (Electronic) Linking ISSN: 07487983 NLM ISO Abbreviation: Eur J Surg Oncol Subsets: MEDLINE

Cho BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: CBC1971@yuhs.ac.; Li W; Department of Pulmonary Care and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.; Spira AI; Virginia Cancer Specialists, Fairfax, Virginia.; Sauder M; University of Toronto, Toronto, Ontario, Canada; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Feldman J; EGFR Resisters, Deerfield, Illinois.; Bozorgmehr F; Thoraxklinik Heidelberg gGmbH, University Hospital Heidelberg, Heidelberg, Germany.; Mak M; Instituto do Câncer do Estado de São Paulo - Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.; Smith J; University of California - Irvine, Irvine, California.; Voon PJ; Department of Radiotherapy and Oncology, Sarawak General Hospital, Kuching, Sarawak, Malaysia.; Liu B; Harbin Medical University Cancer Hospital, Harbin, People's Republic of China.; Tian P; Department of Pulmonary Care and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.; Tan JL; Department of Medicine, University of Malaya, Kuala Lumpur, Malaysia.; Yang CT; Department of Internal Medicine, Division of Thoracic Medicine, Linkou Chang Gung Memorial Hospital; College of Medicine, Chang Gung University, Taoyuan, Taiwan.; Shih JY; Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan.; Karadurmus N; Gülhane Training and Research Hospital, Ankara, Turkey.; Cundom JE; Instituto Argentino de Diagnóstico y Tratamiento (IADT), Buenos Aires, Argentina.; Bertollo G; AFECC/Hospital Santa Rita de Cássia, Vitória-ES, Brazil.; Cicin I; İstinye University Medical Oncology and İ.A.Ü. VM Medical Park Florya Hospital, Istanbul, Turkey.; Nieva J; University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, California.; Ortega-Granados AL; Servicio de Oncologia Médica, Hospital Universitario de Jaén, Jaén, Spain.; Tomasini P; Hôpitaux de Marseille, Aix-Marseille University, Marseille, France.; Nguyen D; City of Hope National Medical Center, Duarte, California.; Felip E; Medical Oncology Service, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.; Schuchard J; Johnson & Johnson, Horsham, Pennsylvania.; Murphy SP; Johnson & Johnson, Raritan, New Jersey.; Anderson BG; Johnson & Johnson, Raritan, New Jersey.; Romero T; Johnson & Johnson, Raritan, New Jersey.; Xia Y; Johnson & Johnson, Spring House, Pennsylvania.; Sheng S; Johnson & Johnson, Raritan, New Jersey.; Bauml JM; Johnson & Johnson, Spring House, Pennsylvania.; Mahadevia PJ; Johnson & Johnson, Raritan, New Jersey.; Kam J; Johnson & Johnson, Raritan, New Jersey.; Nematian-Samani M; Johnson & Johnson, Raritan, New Jersey.; Simoes J; Johnson & Johnson, Raritan, New Jersey.; Wildgust M; Johnson & Johnson, Raritan, New Jersey.; Girard N; Institut du Thorax Curie-Montsouris, Paris, France; Paris-Saclay University, UVSQ-Versailles, France.

Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

Krebs MG; Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, United Kingdom. Electronic address: matthew.krebs@nhs.net.; Cho BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.; Hiret S; Medical Oncology Department, Institut de Cancérologie de l'Ouest, Saint-Herblain, France.; Han JY; National Cancer Center, Goyang-si, Republic of Korea.; Lee KH; Chungbuk National University Hospital, Cheongju, Republic of Korea.; Pérez CL; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIsnowMA, Málaga, Spain.; De Braud F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Haura EB; H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.; Sanborn RE; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon.; Chih-Hsin Yang J; National Taiwan University Cancer Center, Taipei, Taiwan.; Shu CA; Columbia University Medical Center, New York, New York.; Goto K; National Cancer Center Hospital East, Kashiwa, Japan.; Nishio M; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.; Zhao J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Thoracic Oncology, Peking University Cancer Hospital and Institute, Beijing, People's Republic of China.; Wang Z; State Key Laboratory of Molecular Oncology, CAMS Key Laboratory of Translational Research on Lung Cancer, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.; Tomasini P; Aix Marseille University - CNRS, INSERM, CRCM; CEPCM - AP-HM Hopital de La Timone, Marseille, France.; Felip E; Medical Oncology Service, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.; Goldman JW; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.; Ignatius Ou SH; University of California Irvine School of Medicine, Orange, California.; Boyer M; Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia.; Gao G; Johnson & Johnson, Shanghai, People's Republic of China.; Qu S; Johnson & Johnson, Spring House, Pennsylvania.; Curtin JC; Johnson & Johnson, Raritan, New Jersey.; Lyu X; Johnson & Johnson, Shanghai, People's Republic of China.; Schnepp RW; Johnson & Johnson, Spring House, Pennsylvania.; Kim P; Johnson & Johnson, Spring House, Pennsylvania.; Thayu M; Johnson & Johnson, Spring House, Pennsylvania.; Knoblauch RE; Johnson & Johnson, Spring House, Pennsylvania.; Lorenzini P; Johnson & Johnson, Spring House, Pennsylvania.; Baig M; Johnson & Johnson, Raritan, New Jersey.; Spira AI; Virginia Cancer Specialists, Fairfax, Virginia.; Leighl NB; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

Thomas PA; Department of Thoracic Surgery, Diseases of the Esophagus and Lung Transplantation, Assistance Publique-Hôpitaux de Marseille and Aix-Marseille University, Hôpital Nord, Marseille, France.; Braggio C; Department of Thoracic Surgery, Diseases of the Esophagus and Lung Transplantation, Assistance Publique-Hôpitaux de Marseille and Aix-Marseille University, Hôpital Nord, Marseille, France.; Fourdrain A; Department of Thoracic Surgery, Diseases of the Esophagus and Lung Transplantation, Assistance Publique-Hôpitaux de Marseille and Aix-Marseille University, Hôpital Nord, Marseille, France.; Vasse M; Department of Thoracic Surgery, Diseases of the Esophagus and Lung Transplantation, Assistance Publique-Hôpitaux de Marseille and Aix-Marseille University, Hôpital Nord, Marseille, France.; Brioude G; Department of Thoracic Surgery, Diseases of the Esophagus and Lung Transplantation, Assistance Publique-Hôpitaux de Marseille and Aix-Marseille University, Hôpital Nord, Marseille, France.; Trousse D; Department of Thoracic Surgery, Diseases of the Esophagus and Lung Transplantation, Assistance Publique-Hôpitaux de Marseille and Aix-Marseille University, Hôpital Nord, Marseille, France.; Boulate D; Department of Thoracic Surgery, Diseases of the Esophagus and Lung Transplantation, Assistance Publique-Hôpitaux de Marseille and Aix-Marseille University, Hôpital Nord, Marseille, France.; Dales JP; Department of Pathology, Assistance Publique-Hôpitaux de Marseille and Aix-Marseille University, Hôpital Nord, Marseille, France.; Doddoli C; Department of Thoracic Surgery, Diseases of the Esophagus and Lung Transplantation, Assistance Publique-Hôpitaux de Marseille and Aix-Marseille University, Hôpital Nord, Marseille, France.; Tomasini P; Multidisciplinary Oncology and Therapeutic Innovations Department, Assistance Publique-Hôpitaux de Marseille and Aix-Marseille University, Hôpital Nord, Marseille, France.; D'journo XB; Department of Thoracic Surgery, Diseases of the Esophagus and Lung Transplantation, Assistance Publique-Hôpitaux de Marseille and Aix-Marseille University, Hôpital Nord, Marseille, France.; Greillier L; Multidisciplinary Oncology and Therapeutic Innovations Department, Assistance Publique-Hôpitaux de Marseille and Aix-Marseille University, Hôpital Nord, Marseille, France.

Publisher: Oxford University Press Country of Publication: Germany NLM ID: 8804069 Publication Model: Print Cited Medium: Internet ISSN: 1873-734X (Electronic) Linking ISSN: 10107940 NLM ISO Abbreviation: Eur J Cardiothorac Surg Subsets: MEDLINE

Connell E; Dermatology and Skin Cancer Department, Aix Marseille University, APHM, CRCM Inserm U1068, CNRS U7258, Marseille, France.; Department of Early Phase Cancer Trial Center (CEPCM) 'CLIP2,' Aix Marseille University, APHM, Marseille, France.; Gerard É; Dermatology Department, CHU de Bordeaux, Bordeaux, France.; Oules B; Dermatology Department, Cochin Hospital, Paris, France.; Brunet-Possenti F; Dermatology Department, Bichat Claude-Bernard Hospital, Paris, France.; Lamoureux A; Dermatology Department, Montpellier Cancer Institute, Montpellier, France.; Bonnefille H; Dermatology Department, CHU de Nîmes, Nîmes, France.; Mary-Prey S; Dermatology Department, CHU de Bordeaux, Bordeaux, France.; Carrasquilla A; Dermatology Department, Leon Bérard Cancer Center, Lyon, France.; Mouret S; Dermatology Department, CHU Grenoble Alpes, University Grenoble Alpes, INSERM U 1209, CNRS UMR 5309, Institut for Advanced Biosciences, Grenoble, France.; Kramkimel N; Dermatology Department, Cochin Hospital, Paris, France.; Lesage C; Dermatology Department, CHU de Montpellier, Montpellier, France.; Stoebner PE; Dermatology Department, CHU de Nîmes, Nîmes, France.; Bartoli A; Radiology Department, Aix Marseille University, APHM, CERIMED, Marseille, France.; Monestier S; Dermatology and Skin Cancer Department, Aix Marseille University, APHM, CRCM Inserm U1068, CNRS U7258, Marseille, France.; Department of Early Phase Cancer Trial Center (CEPCM) 'CLIP2,' Aix Marseille University, APHM, Marseille, France.; Correard F; Pharmacy Department, Aix Marseille University, APHM, Marseille, France.; Gros A; Tumor Biology and Tumor Bank Department, University Hospital of Bordeaux, Bordeaux, France.; Jeanson A; Department of Early Phase Cancer Trial Center (CEPCM) 'CLIP2,' Aix Marseille University, APHM, Marseille, France.; Multidisciplinary Oncology and Therapeutic Innovations Department, Aix Marseille University, CNRS, INSERM, CRCM, APHM, Marseille, France.; Ouafik L; Oncobiology Department, Aix Marseille University, APHM, CNRS, INP, Inst Neurophysiopathol, Marseille, France.; Gaudy-Marqueste C; Dermatology and Skin Cancer Department, Aix Marseille University, APHM, CRCM Inserm U1068, CNRS U7258, Marseille, France.; Department of Early Phase Cancer Trial Center (CEPCM) 'CLIP2,' Aix Marseille University, APHM, Marseille, France.; Tomasini P; Department of Early Phase Cancer Trial Center (CEPCM) 'CLIP2,' Aix Marseille University, APHM, Marseille, France.; Multidisciplinary Oncology and Therapeutic Innovations Department, Aix Marseille University, CNRS, INSERM, CRCM, APHM, Marseille, France.; Charles J; Dermatology Department, CHU Grenoble Alpes, University Grenoble Alpes, INSERM U 1209, CNRS UMR 5309, Institut for Advanced Biosciences, Grenoble, France.; Amini-Adle M; Dermatology Department, Leon Bérard Cancer Center, Lyon, France.; Malissen N; Dermatology and Skin Cancer Department, Aix Marseille University, APHM, CRCM Inserm U1068, CNRS U7258, Marseille, France.; Department of Early Phase Cancer Trial Center (CEPCM) 'CLIP2,' Aix Marseille University, APHM, Marseille, France.

Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Wickel J; Section of Translational Neuroimmunology, Department of Neurology, Jena University Hospital, Jena, Germany.; Chung HY; Section of Translational Neuroimmunology, Department of Neurology, Jena University Hospital, Jena, Germany.; Ceanga M; Section of Translational Neuroimmunology, Department of Neurology, Jena University Hospital, Jena, Germany.; von Stackelberg N; Section of Translational Neuroimmunology, Department of Neurology, Jena University Hospital, Jena, Germany.; Hahn N; Section of Translational Neuroimmunology, Department of Neurology, Jena University Hospital, Jena, Germany.; Candemir Ö; Section of Translational Neuroimmunology, Department of Neurology, Jena University Hospital, Jena, Germany.; Baade-Büttner C; Section of Translational Neuroimmunology, Department of Neurology, Jena University Hospital, Jena, Germany.; Mein N; Section of Translational Neuroimmunology, Department of Neurology, Jena University Hospital, Jena, Germany.; Tomasini P; Section of Translational Neuroimmunology, Department of Neurology, Jena University Hospital, Jena, Germany.; Woldeyesus DM; Section of Translational Neuroimmunology, Department of Neurology, Jena University Hospital, Jena, Germany.; Andreas N; Department of Neurosurgery, Jena University Hospital, Jena, Germany.; Baumgarten P; Department of Neurosurgery, Jena University Hospital, Jena, Germany.; Koch P; Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Jena, Germany.; Groth M; Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Jena, Germany.; Wang ZQ; Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Jena, Germany.; Faculty of Biological Sciences, Friedrich-Schiller-University, Jena, Germany.; State Key Laboratory of Microbial Technology, Shandong University, Qingdao, China.; Geis C; Section of Translational Neuroimmunology, Department of Neurology, Jena University Hospital, Jena, Germany.; Center for Intervention and Research on Adaptive and Maladaptive Brain Circuits Underlying Mental Health (C-I-R-C), Jena-Magdeburg-Halle, Germany.

Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8806785 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-1136 (Electronic) Linking ISSN: 08941491 NLM ISO Abbreviation: Glia Subsets: MEDLINE

Metellus P; Aix Marseille Univ, Centre national de Recherche Scientifique (CNRS), INP, Inst Neurophysiopathol, Marseille, France.; Ramsay Santé, Hôpital Privé Clairval, Département de Neurochirurgie, Marseille, France.; Camilla C; Aix Marseille Univ, Centre national de Recherche Scientifique (CNRS), INP, Inst Neurophysiopathol, Marseille, France.; Aix Marseille Univ, APHM, CHU Timone, Service d'OncoBiologie, Marseille, France.; Bialecki E; Ramsay Santé, Hôpital Privé Clairval, Département de Neurochirurgie, Marseille, France.; Beaufils N; Aix Marseille Univ, APHM, CHU Timone, Service d'OncoBiologie, Marseille, France.; Vellutini C; Aix Marseille Univ, Centre national de Recherche Scientifique (CNRS), INP, Inst Neurophysiopathol, Marseille, France.; Pellegrino E; Aix Marseille Univ, APHM, CHU Timone, Service d'OncoBiologie, Marseille, France.; Tomasini P; Aix Marseille Univ, APHM, Oncologie multidisciplinaire et innovations thérapeutiques, Marseille, France.; Aix-Marseille Univ, Centre national de Recherche Scientifique (CNRS), Inserm, CRCM, Marseille, France.; Ahluwalia MS; Miami Cancer Institute, Baptist Health South Florida, Miami, FL, United States.; Herbert Wertheim College of Medicine, Florida International University, Miami, FL, United States.; Mansouri A; Department of Neurosurgery, Penn State Cancer Institute, Hershey, PA, United States.; Nanni I; Aix Marseille Univ, APHM, CHU Timone, Service d'OncoBiologie, Marseille, France.; Ouafik L; Aix Marseille Univ, Centre national de Recherche Scientifique (CNRS), INP, Inst Neurophysiopathol, Marseille, France.; Aix Marseille Univ, APHM, CHU Timone, Service d'OncoBiologie, Marseille, France.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Skoulidis F; University of Texas MD Anderson Cancer Center, Houston, TX, USA. fskoulidis@mdanderson.org.; Li BT; Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, New York, NY, USA.; AstraZeneca, Gaithersburg, MD, USA.; de Langen AJ; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Hong DS; University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lena H; Centre Hospitalier Universitaire de Rennes-Hôpital Pontchaillou, Rennes, France.; Wolf J; Center for Integrated Oncology, University Hospital Cologne, Cologne, Germany.; Dy GK; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Curioni Fontecedro A; Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.; Cantonal Hospital of Fribourg, Fribourg, Switzerland.; Tomasini P; Aix Marseille University, APHM, INSERM, NCRS, CRCM, Hôpital Nord, Multidisciplinary Oncology and Therapeutic Innovations Department, Marseille, France.; Velcheti V; Perlmutter Cancer Center, New York University Langone, New York, NY, USA.; van der Wekken AJ; Department of Pulmonology and Tuberculosis, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.; Dooms C; Department of Respiratory Diseases, University Hospitals KU Leuven, Leuven, Belgium.; Paz-Ares Rodriguez L; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Mountzios G; Fourth Department of Medical Oncology and Clinical Trials Unit, Henry Dunant Hospital Center, Athens, Greece.; Sacher A; Princess Margaret Cancer Centre, Toronto, ON, Canada.; Nadal E; Catalan Institute of Oncology (ICO), IDIBELL, L'Hospitalet, Barcelona, Spain.; Couraud S; Cancer Institute of Hospices Civils de Lyon, Lyon Sud Hospital, Pierre Bénite, France.; Kim SW; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.; O'Byrne K; Princess Alexandra Hospital and Queensland University of Technology, Brisbane, Queensland, Australia.; Rocco D; Department of Pulmonary Oncology, AORN dei Colli Monaldi, Naples, Italy.; Toyozawa R; Department of Thoracic Oncology, NHO Kyushu Cancer Center, Fukuoka, Japan.; Chmielewska I; Department of Pneumonology, Oncology and Allergology, Medical University of Lublin, Lublin, Poland.; Lindsay CR; The Christie NHS Foundation Trust, Manchester, UK.; Division of Cancer Sciences, University of Manchester, Manchester, UK.; Hindoyan A; Amgen, Inc., Thousand Oaks, CA, USA.; Mukundan L; Amgen, Inc., Thousand Oaks, CA, USA.; Wilmanski T; Amgen, Inc., Thousand Oaks, CA, USA.; Anderson A; Amgen, Inc., Thousand Oaks, CA, USA.; Ardito-Abraham C; Amgen, Inc., Thousand Oaks, CA, USA.; Pati A; Amgen, Inc., Thousand Oaks, CA, USA.; Reddy A; Amgen, Inc., Thousand Oaks, CA, USA.; Mehta B; Amgen, Inc., Thousand Oaks, CA, USA.; Schuler M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany. martin.schuler@ume.de.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Nakazawa S; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan.; Pecci F; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Odintsov I; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Gazgalis D; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Gottlieb FH; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Zullo L; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.; Alessi JV; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Di Federico A; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Aldea M; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.; Paris Saclay University, Kremlin-Bicetre, France.; Garbo E; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Gandhi MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Saini A; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Feng WW; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Jiang J; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Baldacci S; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Facchinetti F; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Makarem M; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Locquet MA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Haratani K; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Haradon D; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Besse B; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.; Paris Saclay University, Kremlin-Bicetre, France.; Italiano A; Department of Drug Development, Precision Medicine Group, Gustave Roussy, Villejuif, France.; Department of Medicine, Institut Bergonié, Bordeaux, France.; University of Bordeaux, Bordeaux, France.; Remon J; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.; Lavaud P; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.; Vasseur D; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France.; Planchard D; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.; Paris Saclay University, Kremlin-Bicetre, France.; Sato Y; Center for Research on Green Sustainable Chemistry, Tottori University, Tottori, Japan.; Department of Chemistry and Biotechnology, Graduate School of Engineering, Tottori University, Tottori, Japan.; Watanabe Y; Department of Breast Surgery, School of Medicine, International University of Health and Welfare, Chiba, Japan.; Owen S; McGill University Health Center - Research Institute, Montreal, Canada.; Cortot AB; Univ. Lille, CHU Lille, CNRS, Inserm, Institut Pasteur de Lille, UMR9020-UMR1277-Canther-Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille, France.; Mahran H; UCL Cancer Institute/University College London Hospitals NHS Foundation Trust, London, United Kingdom.; Forster MD; UCL Cancer Institute/University College London Hospitals NHS Foundation Trust, London, United Kingdom.; Niu J; Banner MD Anderson Cancer Center, Gilbert, Arizona.; Tomasini P; Aix Marseille University - CNRS, INSERM, CRCM, CEPCM - AP-HM Hopital de La Timone, Marseille, France.; Leong SS; Oncocare Cancer Centre, Singapore, Singapore.; Tay K; Oncocare Cancer Centre, Singapore, Singapore.; Esteban E; Hospital Universitario Central de Asturias, Asturias, Spain.; Minchom A; Royal Marsden Hospital/Institute of Cancer Research, Surrey, United Kingdom.; Kizilbash SH; Mayo Clinic, Rochester, Minnesota.; Cruz-Correa M; Pan American Center for Oncology Trials, San Juan, Puerto Rico.; University of Puerto Rico School of Medicine, San Juan, Puerto Rico.; Yu KP; Apollomics, Inc., Foster City, California.; Zhang X; Apollomics, Inc., Foster City, California.; Chen P; Apollomics, Inc., Foster City, California.; Sangem M; Apollomics, Inc., Foster City, California.; Che J; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Sholl LM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Jänne PA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Awad MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

Benzekry S; COMPutational Pharmacology and Clinical Oncology Department, Inria Sophia Antipolis - Méditerranée, Faculté de Pharmacie, Cancer Research Center of Marseille, Inserm UMR1068, CNRS UMR7258, Aix Marseille University UM105, 27 Boulevard Jean Moulin, 13005, Marseille, France. sebastien.benzekry@inria.fr.; Schlicke P; Department of Mathematics, TUM School of Computation, Information and Technology, Technical University of Munich, Garching (Munich), Germany.; Mogenet A; Multidisciplinary Oncology and Therapeutic Innovations Department, Assistance Publique - Hôpitaux de Marseille, Aix Marseille University, Marseille, France.; Greillier L; Multidisciplinary Oncology and Therapeutic Innovations Department, Assistance Publique - Hôpitaux de Marseille, Aix Marseille University, Marseille, France.; Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France.; Tomasini P; Multidisciplinary Oncology and Therapeutic Innovations Department, Assistance Publique - Hôpitaux de Marseille, Aix Marseille University, Marseille, France.; Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France.; Simon E; Multidisciplinary Oncology and Therapeutic Innovations Department, Assistance Publique - Hôpitaux de Marseille, Aix Marseille University, Marseille, France.

Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 8409970 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7276 (Electronic) Linking ISSN: 02620898 NLM ISO Abbreviation: Clin Exp Metastasis Subsets: MEDLINE

Passaro A; Wang Y; Lee SH; Melosky B; Shih JY; Wang J; Azuma K; Juan-Vidal O; Cobo M; Felip E; Girard N; Cortot AB; Califano R; Cappuzzo F; Owen S; Popat S; Tan JL; Salinas J; Tomasini P; Gentzler RD; William WN Jr; Reckamp KL; Takahashi T; Ganguly S; Kowalski DM; Bearz A; MacKean M; Barala P; Bourla AB; Girvin A; Greger J; Millington D; Withelder M; Xie J; Sun T; Shah S; Diorio B; Knoblauch RE; Bauml JM; Campelo RG; Cho BC

ANNALS OF ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Gautschi O; University of Berne and Medical Oncology, Cantonal Hospital of Lucerne, Lucerne, Switzerland.; Park K; Division of Heamatology/Oncology, Medicine, Samsung Medical Center (SMC)-Sungkyunkwan University School of Medicine, Seoul, Korea.; Department of Thoracic/Head & Neck Medical Oncology, UT MD Anderson Cancer Center, Houston, TX.; Solomon BJ; Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Australia.; Tomasini P; Centre Georges-François Leclerc, Dijon, France.; Loong HH; Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.; De Braud F; Medical Oncology & Haematology Department, Fondazione IRCCS-Istituto Nazionale dei Tumori, Milan, Italy.; Goto K; National Cancer Center Hospital East, Kashiwa, Japan.; Peterson P; Eli Lilly and Company, Indianapolis, IN.; Barker S; Eli Lilly and Company, Indianapolis, IN.; Liming K; Eli Lilly and Company, Indianapolis, IN.; Oxnard GR; Eli Lilly and Company, Indianapolis, IN.; Frimodt-Moller B; Eli Lilly and Company, Copenhagen, Denmark.; Drilon A; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center, New York, NY.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Horinouchi H; National Cancer Center Hospital, Tokyo, Japan.; Cho BC; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; Camidge DR; Department of Medicine, University of Colorado Cancer Center, Aurora, USA.; Goto K; National Cancer Center Hospital East, Kashiwa, Japan.; Tomasini P; Multidisciplinary Oncology and Therapeutic Innovations Department, Aix Marseille University, APHM, INSERM, CNRS, CRCM, Hôpital Nord, Marseille, France.; Li Y; AbbVie Inc, North Chicago, USA.; Vasilopoulos A; AbbVie Inc, North Chicago, USA.; Brunsdon P; AbbVie Inc, North Chicago, USA.; Hoffman D; AbbVie Inc, North Chicago, USA.; Shi W; AbbVie Inc, North Chicago, USA.; Bolotin E; AbbVie Inc, North Chicago, USA.; Blot V; AbbVie Inc, North Chicago, USA.; Goldman J; David Geffen School of Medicine at UCLA, Los Angeles, USA. Electronic address: jwgoldman@mednet.ucla.edu.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Besse B; Paris-Saclay University, Institut Gustave Roussy, Villejuif, France.; Goto K; National Cancer Center Hospital East, Kashiwa, Japan.; Wang Y; Institute of Clinical Trial Center and Cancer Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China.; Lee SH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Marmarelis ME; University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania.; Ohe Y; National Cancer Center Hospital, Tokyo, Japan.; Bernabe Caro R; Hospital Universitario Virgen Del Rocio, Seville, Spain.; Kim DW; Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea.; Lee JS; Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea.; Cousin S; Institut Bergonié, Bordeaux, France.; Ichihara E; Center for Clinical Oncology, Okayama University Hospital, Okayama, Japan.; Li Y; Chongqing University Cancer Hospital, Chongqing, People's Republic of China.; Paz-Ares L; Hospital Universitario 12 de Octubre, Madrid, Spain.; Ono A; Shizuoka Cancer Center, Shizuoka, Japan.; Sanborn RE; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon.; Watanabe N; Department of Thoracic Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan.; de Miguel MJ; START Madrid-CIOCC, Hospital HM Sanchinarro, Madrid, Spain.; Helissey C; Clinical Research unit, Military Hospital Begin, Saint-Mandé, France.; Shu CA; Columbia University Medical Center, New York, New York.; Spira AI; Virginia Cancer Specialists, Fairfax, Virginia.; Tomasini P; Aix Marseille University - CNRS, INSERM, CRCM; CEPCM - AP-HM Hopital de La Timone, Marseille, France.; Yang JC; National Taiwan University Cancer Center, Taipei, Taiwan.; Zhang Y; Zhejiang Cancer Hospital, Hangzhou, People's Republic of China.; Felip E; Medical Oncology Service, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital Campus, Universitat Autonoma de Barcelona, Barcelona, Spain.; Griesinger F; Pius-Hospital, University Medicine of Oldenburg, Oldenburg, Germany.; Waqar SN; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.; Calles A; Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Neal JW; Stanford University Medical Center, Stanford, California.; Baik CS; University of Washington, Fred Hutchinson Cancer Center, Seattle, Washington.; Jänne PA; Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.; Shreeve SM; Johnson & Johnson, San Diego, California.; Curtin JC; Johnson & Johnson, Spring House, Pennsylvania.; Patel B; Johnson & Johnson, Spring House, Pennsylvania.; Gormley M; Johnson & Johnson, Spring House, Pennsylvania.; Lyu X; Johnson & Johnson, Shanghai, People's Republic of China.; Chen J; Johnson & Johnson, Spring House, Pennsylvania.; Chu PL; Johnson & Johnson, Raritan, New Jersey.; Mahoney J; Johnson & Johnson, Spring House, Pennsylvania.; Trani L; Johnson & Johnson, Spring House, Pennsylvania.; Bauml JM; Johnson & Johnson, Spring House, Pennsylvania.; Thayu M; Johnson & Johnson, Spring House, Pennsylvania.; Knoblauch RE; Johnson & Johnson, Spring House, Pennsylvania.; Cho BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: CBC1971@yuhs.ac.

Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

Mogenet A; Multidisciplinary Oncology and Therapeutic Innovations Department, Assistance publique - Hôpitaux de Marseille, Aix Marseille University, Marseille, France; Aix Marseille University, CNRS, Inserm, CRCM, Marseille, France.; Greillier L; Multidisciplinary Oncology and Therapeutic Innovations Department, Assistance publique - Hôpitaux de Marseille, Aix Marseille University, Marseille, France; Aix Marseille University, CNRS, Inserm, CRCM, Marseille, France.; Tomasini P; Multidisciplinary Oncology and Therapeutic Innovations Department, Assistance publique - Hôpitaux de Marseille, Aix Marseille University, Marseille, France; Aix Marseille University, CNRS, Inserm, CRCM, Marseille, France. Electronic address: pascale.tomasini@ap-hm.fr.

Publisher: Elsevier Country of Publication: France NLM ID: 0072416 Publication Model: Print Cited Medium: Internet ISSN: 1769-6917 (Electronic) Linking ISSN: 00074551 NLM ISO Abbreviation: Bull Cancer Subsets: MEDLINE